It’s already common news that Aspirin provides several benefits for the body and is of great use in the treatment of several health conditions. Now, scientists with a research center in Australia’s Melbourne have finally found the data to help them explain Aspirin’s positive role in cancer treatment.
The findings of the Australian study pave the way for new cancer treatments that will limit the tumors from spreading. Scientists at Melbourne’s Peter MacCallum Cancer Centre, announced this Tuesday that Aspirin and other household drugs are able to inhibit the spread of cancer because these anti-inflammatory drugs are able to help close the chemical “highways” that are responsible for the feeding of tumors.
Scientists in Melbourne are so excited about their findings they said they have made a biological breakthrough as they have identified the reactions lymphatic vessels have when they are attacked by cancer.
Steven Stacker with the study said: “We’ve shown that molecules like the aspirin…could effectively work by reducing the dilation of these major vessels and thereby reducing the capacity of tumours to spread to distant sites”.
In their study of cells in lymphatic vessels, researchers found a particular gene that had changed it expression in cancer which spread, but not when the cancer did not spread. The gene seems to be the link between the tumour’s growth and the cellular pathway that is responsible for causing inflammation and dilation of vessels throughout the body.
Stacker explained their findings as “a pivotal junction point in a biochemical sense between all these different contributors”.
Meanwhile, another study featured in Forbes shows that use of aspirin can reduce the risk of cardiovascular events, but it should not be used routinely in people without a history of cardiovascular diseases.
The research combined data from 9 clinical studies and looked at more than 100,000 participants. Authors of the study found a significant reduction in cardiovascular events, but not in cardiovascular mortality along with an increased risk of important bleeding events.
Since there aren’t any further studies on the matter, researchers point out that there’s need for a reappraisal of current guidelines regarding aspirin therapy and the patients who actually need it.